ZUG, Switzerland, Dec. 10, 2025 /PRNewswire/ — Berlin Heals Holding AG (Zug, Switzerland) is pleased to announce the appointment of Rob ten Hoedt as the new Chairman of the Board of Directors.

“We are thrilled to welcome someone of Rob ten Hoedt’s caliber to the Board,” said Marko Bagaric, Co-founder and Member of the Board of Directors. “His global impact on healthcare systems and deep expertise in medical technology will positively affect our progress and give us even more momentum for the exciting year ahead.”

Rob ten Hoedt brings more than three decades of global leadership in the medical technology and healthcare sectors, most recently serving as Executive Vice President and President, Global Regions, at Medtronic. Prior to that, he held senior leadership roles at Medtronic SQDM, Vitatron, and Urologix. Rob holds a degree in Commercial Economy from the H.E.A.O. in the Netherlands and a Master’s in Marketing from NIMA Business School. He currently serves as Chairman of the Board of Directors at Medmix and Onward Medical and is a member of the board of Fagron International.

“I am very excited to join the Board of Directors at Berlin Heals Holding AG and to contribute to its revolutionary new therapy in Heart Failure. Together, we will strive to bring the life-changing benefits of the C-MIC device to patients worldwide. A thrilling time lies ahead, and it is an honor to be part of it,” said Mr. ten Hoedt.

“We are delighted to welcome Rob ten Hoedt as our new Chairman of the Board of Directors as we enter a pivotal year for Berlin Heals,” said John Brumfield, Chief Executive Officer of Berlin Heals Holding AG. “His knowledge, leadership experience, and genuine passion for innovation will play an instrumental role in shaping our strategy and driving further growth.”

About CMIC Therapy

Cardiac Microcurrent (C-MIC) Therapy is delivered via a fully implantable medical device that consists of two electrodes connected to an implantable generator that provides constant direct microcurrent across the diseased heart. This constant DC current reduces inflammation and reverse remodels the heart that has been shown in previous studies to improve cardiac function and reduce symptoms. The first generation required a minimally invasive surgical procedure where a cardiothoracic surgeon placed an electrode on the outside of the heart. The new Less Invasive approach can be implanted in a cardiac catheterization lab through a conscious sedation out-patient procedure by a Cardiologist.

About Heart Failure

Heart Failure is a condition where the heart is weakened and cannot meet the body’s demand for blood flow. Symptoms include shortness of breath, fatigue and palpitations limiting ability to perform daily activities. The progressive disease leads to high frequency of hospital admissions, poor clinical outcomes and high cost of care. Heart Failure is a Global Pandemic that affects over 64 Million people around the world. In the western world, 1 in 4 people will develop the disease in their lifetime. The Global cost of Heart Failure care is rising dramatically to an estimated $858Billion annually by 2050. The disease is a leading cause of death with worse mortality than cancer. There is currently no commercially available cure.

About Berlin Heals Holding AG

Berlin Heals Holding is developing a novel treatment to reverse remodel and recover from Heart Failure. After a successful First-In-Human study in 2019 followed by sustaining long-term results and a successful Randomized Controlled Trial completed in 2024, the company has been developing a new approach to implant the device less invasively in an outpatient cardiac cath lab procedure. The company is based in Zug, Switzerland with subsidiaries in Germany and the United States.

NINGBO, China, Dec. 10, 2025 /PRNewswire/ — Recently, Risen Energy announced the signing of a 3 GWh energy storage system cooperation MOU with WEG, a leading Brazilian industrial giant. Pursuant to the MOU, Risen Energy will supply WEG with advanced utility-scale and commercial & industrial ESS from 2026 to 2028, supporting global energy structure optimization and the green, low-carbon transition.

Founded in 1961 and headquartered in Santa Catarina, Brazil, WEG is one of Latin America’s largest electrical equipment manufacturers, with operations spanning over 140 countries worldwide. The company has deep expertise in renewable energy, industrial energy efficiency, and smart grid technologies. In recent years, WEG has actively expanded into energy storage and integrated energy services, aiming to deliver efficient, reliable, and sustainable energy infrastructure across global markets.

Risen Storage has been dedicated to the lithium battery industry for 20 years, integrating R&D, manufacturing, sales, and services. Its products include PCS, BMS, EMS, C&I, and Utility-Scale ESS. Notably, its Energy Storage Battery System was the first in China to achieve UL9540A certification in both the U.S. and China. Through the deep integration of 4S technology, Risen Storage has developed self-engineered BESS solutions for all applications. These solutions are applicable in renewable energy integration, peak shaving, frequency regulation, demand response, backup power, microgrids, and other applications. The company remains committed to transforming the energy landscape through technological innovation.

This strategic partnership not only marks a critical step forward for Risen Energy and WEG in building next-generation power systems but also represents a truly global collaboration. Risen Energy will supply ESS for WEG’s projects across multiple regions—including South America, North America, Europe, Africa, and Australia—signaling an upgrade from regional cooperation to a comprehensive global strategic alignment. In fact, Risen Energy and WEG have a long-standing partnership in the photovoltaic sector. This expanded collaboration into energy storage underscores WEG’s renewed confidence in Risen Energy’s technical capabilities and global delivery track record.

From bringing stable electricity to remote villages in South America and lighting up thousands of households, to enabling energy transitions for industrial parks in North America; from supporting residential solar-plus-storage systems in Europe to empowering off-grid communities in Africa with green microgrids—Risen Energy’s business now spans more than 90 countries and regions worldwide. Moving forward, Risen Energy will continue to partner with WEG and other global collaborators, leveraging its safe, reliable, and fully in-house developed solar-plus-storage technologies to deploy green energy solutions across diverse regions and applications—accelerating the global transition toward a more efficient, resilient, and sustainable energy system.

HONG KONG, Dec. 10, 2025 /PRNewswire/ — CSOP HSCEI Covered Call Active ETF (2802.HK) will be listed on the Hong Kong Stock Exchange on 11 December 2025. 2802.HK seeks to achieve its investment objective by primarily (i) investing in constituent equity securities in the Hang Seng China Enterprises Index (HSCEI); and (ii) selling call options on HSCEI to receive call options premium. 2802.HK has a listing price of 8.8 HKD per unit, trading unit of 100, and management fee of 0.99%. An unlisted class is also available to investors.

CSOP HSCEI Covered Call Active ETF (2802.HK) targets monthly distributions generated by dividends from the underlying stocks on top of option premiums, making it appealing to income-focused investors seeking higher yields (Dividend rate is not guaranteed and may be paid out of the capital)^[1]. Serving as a partial cushion against market downturns, option premiums can help reduce losses and portfolio volatility compared to just holding stocks. The HSCEI covered call strategy performs more resilient in a declining market compared to the HSCEI alone. For instance, between August 2023 and March 2024, the HSCEI covered call strategy returned 2.86%, while the HSCEI recorded a decline of 7.53%^[2]. With strong derivatives experience managing US$8.6 billion in derivatives^[3], CSOP Asset Management (CSOP) offers professional expertise, giving investors easy access to covered call strategies without the complexity of self-management.

A covered call strategy is an options trading strategy that involves holding a long position in a particular asset (for example, a stock, a commodity, a bond, a currency, or an index) while simultaneously writing call options on the same asset. Performance varies by market regime. The strategy tends to perform best in range‑bound markets, where premium income can provide more stable returns and assignment risk is lower. A bullish market scenario typically yields the lowest return for a covered call strategy. Call option exercise forces a cash payment or the liquidation of long-position assets. Upside is limited to the call option’s strike price plus the premium received. In bearish markets, the option premium offsets some losses from a market drop. However, the premium may not fully cover sharp market declines.

Ms. Ding Chen, CEO of CSOP states, “Since our establishment in 2008, CSOP has consistently sought to provide high quality, innovative investment tools to Asian investors. Today, we are proud to introduce the CSOP HSCEI Covered Call Active ETF (2802.HK), offering investors a new income‑generating solution that aims to deliver monthly distributions and enhance resilience in volatile markets.”

About CSOP Asset Management

For over a decade, CSOP has successfully established itself as one of the leading ETF issuers in Hong Kong, with second largest AUM and demonstrated innovative product development. As of 30 November 2025, the total AUM of CSOP reached 27.9 billion USD by building a healthy ETF ecosystem and managing 63 ETPs and 4 mutual funds in Hong Kong and Singapore markets*. In 2025, 6 out of the top 10 most actively traded ETPs in Hong Kong are managed by CSOP**.

*Source: CSOP

** Source: Bloomberg, from 2 January 2025 to 28 November 2025

Disclaimer and Important Notices

Investment involves risks. Investors should refer to the Prospectus and the Product Key Facts Statement for further details, including product features and the full list of risk factors. This material is prepared by CSOP Asset Management Limited and has not been reviewed by the Securities and Futures Commission in Hong Kong. Please read the detailed disclosure and disclaimer carefully by accessing website (https://www.csopasset.com/en/education/disclaimer_en_forCoveredCall.html).
Issuer: CSOP Asset Management Limited

[1] The Manager intends to declare and pay monthly dividends. However, there is neither a guarantee that such dividends will be made nor will there be a target level of dividend payout. The Manager may, at its discretion, pay dividend out of capital. Payments of dividends out of capital or effectively out of capital amounts to a return or withdrawal of part of an investor’s original investment or from any capital gains attributable to that original investment. Any distributions involving payment of dividends out of the Sub-Fund’s capital or effectively out of capital may result in an immediate reduction in the Net Asset Value per Unit of the Sub-Fund and will reduce any capital appreciation for the unitholders of the Sub-Fund.

[2] Source: Bloomberg, 2023/8/31-2024/3/28.

[3] Source: The notional amount of derivative (exchange traded futures, swap and listed option) in CSOP’s investment portfolio.